GeneDx Holdings Warrant
WGSWW
WGSWW was delisted on the 21st of July, 2026.
21 hedge funds and large institutions have $46.1K invested in GeneDx Holdings Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
2.74% less ownership
Funds ownership: 20.05% → 17.31% (-2.7%)
5% less funds holding
Funds holding: 22 → 21 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
70% less capital invested
Capital invested by funds: $154K → $46.1K (-$108K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$314 |
| 2 |
CAC
Cowen and Company
New York
|
+$171 |
| 3 |
CS
Clear Street
New York
|
+$3 |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$3 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$9.98K |
| 2 |
GS
Gagnon Securities
New York
|
-$1.11K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$342 |
WGSWW Hedge Fund Activity: Q4 2023 in Review
21 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q4 2023, worth a combined $46.1K — down 70% from $154K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of WGSWW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.
The largest buyer was UBS Group, adding an estimated $314. The largest seller was Ionic Capital Management, cutting an estimated $9.98K.
- 21 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q4 2023, down from 22 in Q3 2023.
- Funds reported $46.1K of GeneDx Holdings Warrant stock for Q4 2023, down 70% quarter-over-quarter.
- 1 fund opened new GeneDx Holdings Warrant positions in Q4 2023 and 2 closed out, a net change of -1 holder.
- The largest GeneDx Holdings Warrant buyer in Q4 2023 was UBS Group, an estimated $314 added.
- The largest GeneDx Holdings Warrant seller in Q4 2023 was Ionic Capital Management, an estimated $9.98K sold.
Based on aggregated 13F filings for Q4 2023.